Advertising in the International Journal of Head and Neck Surgery: A Complete Guide to IJHNS Magazine Advertising Rates, Formats, and Strategy for Pharma and MedTech Brands in India

Most pharmaceutical marketing teams spend considerable energy debating which digital channel to prioritise, yet the brands that consistently build deep credibility among ENT surgeons and head and neck specialists are the ones quietly running well-placed print campaigns in peer-reviewed journals — and the International Journal of Head and Neck Surgery is one of the most targeted vehicles available in India for exactly that purpose. The journal reaches a highly specific, highly qualified audience of clinicians who are, frankly speaking, the very decision-makers that surgical equipment companies and pharma brands need to influence. What a lot of people miss is that medical journal advertising in India remains significantly underpriced relative to the quality of the HCP audience it delivers.

What Is the International Journal of Head and Neck Surgery and Who Publishes It?

The International Journal of Head and Neck Surgery — known across the medical publishing industry by its abbreviation IJHNS — is a peer-reviewed, open access quarterly journal dedicated to the clinical and surgical aspects of head and neck diseases, otolaryngology, and allied specialties. Published by Jaypee Brothers Medical Publishers (P) Ltd., one of India's most established and respected medical publishers, the journal covers original research, case reports, review articles, and clinical updates relevant to ENT surgeons, head and neck oncologists, maxillofacial surgeons, and clinicians working across the broader spectrum of head and neck diseases. The journal carries the ISSN 0975-7899 and is accessible through the Jaypee open access platform at jaypeejournals.com, which means its content — and by extension, any advertising placed within it — reaches readers both in print and through a growing digital readership base.

Jaypee Brothers Medical Publishers (P) Ltd. operates out of New Delhi, with its flagship offices located in Daryaganj on Ansari Road, which has historically been the heart of India's medical publishing ecosystem. Jaypee Brothers, as an institution, has been publishing Indian medical journals and textbooks for several decades; the depth of their distribution network across hospitals, medical colleges, and specialist clinics across India is something that newer digital-only publishers genuinely cannot replicate. The journal is also indexed through PORTICO digital preservation, which signals a commitment to long-term archival integrity — a quality that matters to institutional subscribers and, indirectly, to advertisers whose placements are preserved as part of the journal's permanent record. For brands advertising in India's medical journal space, the Jaypee Brothers imprint carries a weight of credibility that is difficult to quantify but very real in practice.

At SmartAds, we always tell our clients that the publisher behind a journal matters as much as the journal's own metrics. A Jaypee Brothers publication carries institutional trust that extends to the advertisements placed within it; when an ENT surgeon in Coimbatore or Lucknow opens an IJHNS issue, the editorial credibility of the journal creates a halo effect that benefits every brand visible on those pages. This is not a minor consideration — it is, in our experience, one of the primary reasons that pharmaceutical advertising in Indian medical journals continues to deliver results that digital-only campaigns struggle to match among specialist HCP audiences.

Why Should Brands Advertise in a Head and Neck Surgery Medical Journal in India?

The honest answer is that most brands get this wrong — they treat medical journal advertising as a box-ticking exercise rather than as a precision targeting tool, and then wonder why the results feel underwhelming. The International Journal of Head and Neck Surgery exists at the intersection of a very specific clinical community: ENT surgeons, head and neck oncologists, speech therapists working in surgical contexts, and allied specialists who collectively make prescribing and procurement decisions worth thousands of crores annually in India. Reaching this audience through mass media — television, outdoor, even broad digital — is extraordinarily wasteful; the cost per relevant impression balloons to a point where the economics simply do not work. Advertising in IJHNS, by contrast, concentrates your spend on exactly the people who matter for a surgical instrument, a post-operative pharmaceutical, or a diagnostic imaging product.

The case for pharma brands is particularly strong. India's pharmaceutical advertising landscape has evolved considerably over the past few years, with brands increasingly recognising that key opinion leaders — the KOLs who shape prescribing behaviour across entire hospital networks and medical college departments — are disproportionately represented among the readership of peer-reviewed journals like IJHNS. A well-placed full page advertisement in a quarterly issue of the International Journal of Head and Neck Surgery is seen not just by the individual subscriber but, in many cases, by the residents, fellows, and junior consultants who share access to institutional copies. Brand visibility in this context compounds in ways that are genuinely difficult to replicate through a digital banner campaign, however precisely targeted.

MedTech brands and surgical equipment companies, in our experience, have been somewhat slower to recognise this opportunity — which is, frankly speaking, their loss. A company manufacturing endoscopes, surgical lasers, or post-operative wound care products has an almost perfect alignment with the IJHNS readership; the journal's editorial focus on head and neck diseases means that every reader is, by definition, a potential end-user or influencer of the products being advertised. We worked with a surgical equipment distributor — a mid-sized company based in Mumbai — who had previously concentrated their advertising budget entirely on conference sponsorships; when we shifted a portion of that budget into sustained quarterly placements across two Jaypee Brothers journals, including IJHNS, their brand recall among surveyed ENT surgeons improved by a margin that surprised even their own sales team.

What Are the Available Ad Formats in IJHNS — Print, Digital, and Sponsored Supplements?

Print advertising in the International Journal of Head and Neck Surgery follows the standard format hierarchy that most Indian medical journals have adopted, though the specifics matter considerably when planning a campaign. The premium positions — back cover and inside cover placements — command the highest rates and the highest reader attention; a back cover advertisement in a quarterly journal sits in front of the reader every time the issue is picked up, which over the course of a three-month publication cycle represents a meaningful number of impressions. Inside cover placements — both inside front cover and inside back cover — offer similar prominence at a slightly lower rate, which makes them the value-for-money choice for brands that want premium visibility without the full back cover investment. Full page advertisements placed within the body of the journal are the workhorse format for most pharma brands, offering sufficient space for product imagery, clinical claims, and regulatory disclosures; half page advertisements work well for brands with a single, clean message that does not require extensive copy.

Digital advertising through the IJHNS platform on jaypeejournals.com opens a parallel set of ad formats that are worth understanding separately. The Jaypee open access platform attracts a readership that extends well beyond the print subscriber base — researchers, postgraduate students, and clinicians who access the journal online rather than through institutional subscriptions — which means that digital ad placements reach a meaningfully different and, in some ways, larger segment of the head and neck surgery community. Banner ads in the leaderboard position (typically appearing at the top of article pages), mid-page banners, and skyscraper ads running alongside article content are the primary digital ad formats available; these can be purchased on a per-issue cycle basis or as part of a longer digital advertising package. The CPM for these digital placements works out to a figure that, in our experience, surprises most first-time medical journal advertisers — it is considerably lower than what the same brand would pay for a targeted digital campaign on LinkedIn or a medical professional network, yet the audience quality is arguably superior because the reader is actively engaged with clinical content.

Sponsored supplements represent a third, and in many ways the most powerful, advertising format available within the IJHNS ecosystem. A sponsored supplement is a separately bound or digitally published section of the journal, typically produced in collaboration with the advertiser, which contains branded clinical content — case compilations, treatment protocols, expert roundtable summaries, or product-focused clinical reviews — that is clearly labelled as sponsored but benefits from the journal's editorial environment and distribution infrastructure. At SmartAds, we have found that sponsored supplements consistently outperform standard display advertising in terms of brand recall and HCP engagement; the format allows a pharma or MedTech brand to present substantive clinical information in a context that readers find credible and useful, rather than simply asserting a product claim in a display ad. Reprints and e-prints of published articles — particularly those that feature a brand's product in a favourable clinical context — are also available through Jaypee Brothers Medical Publishers, and these serve as powerful leave-behind materials for medical representatives visiting specialist clinics.

How Do You Book an Advertisement in the International Journal of Head and Neck Surgery?

The booking process for advertising in IJHNS, like most Indian medical journals published by Jaypee Brothers, begins with a direct inquiry to the publisher's advertising department. The primary point of contact is the Jaypee Brothers Medical Publishers (P) Ltd. office in New Delhi — the Daryaganj, Ansari Road office handles advertising inquiries for the full portfolio of Jaypee journals, including IJHNS. An initial inquiry should specify the issue you are targeting (IJHNS is a quarterly journal, so planning at least eight to twelve weeks ahead of the desired publication date is strongly advisable), the ad format you are considering — whether a full page advertisement, half page advertisement, back cover, inside cover, or digital banner ad — and any specific placement preferences. The advertising team will respond with a current rate card and a booking confirmation process that typically involves a purchase order from the advertiser's side.

The creative submission requirements for print advertising in IJHNS follow standard Indian medical journal specifications: artwork should be submitted in CMYK colour mode (not RGB, which is a surprisingly common mistake that causes colour shifts in print), at a minimum resolution of 300 DPI, and in PDF or high-resolution TIFF format. The journal ad submission deadline for a given issue typically falls somewhere between four and six weeks before the print date, though this can vary; confirming the exact deadline with the Jaypee Brothers advertising team at the time of booking is essential, because missing the material submission window means waiting an entire quarter for the next issue. For digital ad formats on jaypeejournals.com, the technical specifications differ — web banners are typically submitted as JPEG or PNG files at 72 DPI, with file size limits that the digital team will specify at the time of booking.

Here's where it gets interesting for agencies and brand managers who are managing multiple journal placements simultaneously: the purchase order process at Jaypee Brothers is relatively straightforward, but coordinating creative approvals, regulatory sign-offs (which are mandatory for pharmaceutical advertising in India under OPPI guidelines and the relevant MCI norms), and material submission deadlines across multiple journals in the same quarter requires careful project management. At SmartAds, we handle this coordination on behalf of our pharma and MedTech clients — managing the purchase order process, liaising with the Jaypee Brothers advertising team, and ensuring that all creative materials meet both the publisher's technical specifications and the applicable regulatory requirements before submission. The journal ad submission deadline is not negotiable; we have seen campaigns delayed by an entire quarter because a client's regulatory team took longer than expected to clear the advertising claims.

What Are the Advertising Guidelines and Editorial Independence Policies at IJHNS?

Editorial independence is not a marketing phrase in the context of IJHNS — it is a structural commitment that Jaypee Brothers Medical Publishers has built into the journal's operating framework, and understanding it matters for any brand considering advertising here. The advertising content published in the International Journal of Head and Neck Surgery is entirely separate from the journal's editorial and peer-review processes; no advertiser receives any influence over which research articles are accepted, how they are presented, or what editorial positions the journal takes. This separation is enforced at the publisher level and is consistent with the advertising policy standards that peer-reviewed journals are expected to maintain to retain their indexing status and institutional credibility. For pharma brands, this is actually a selling point rather than a limitation — the editorial independence of the journal is precisely what gives its pages their credibility, and that credibility extends to the advertising environment.

The advertising policy of IJHNS, consistent with Jaypee Brothers' broader journal portfolio standards, requires that all pharmaceutical advertising comply with applicable Indian regulatory frameworks — which means that evidence-based advertising claims are mandatory, and that any clinical claims made in an advertisement must be supportable by published data. The OPPI (Organisation of Pharmaceutical Producers of India) code of pharmaceutical marketing practices is the relevant industry standard for most multinational pharma advertisers; Indian pharmaceutical companies are additionally subject to the Uniform Code of Pharmaceutical Marketing Practices (UCPMP) guidelines. Advertisements that make unsupported clinical claims, promote off-label uses, or present misleading comparative data will not be accepted — and frankly speaking, this is as it should be. The advertising policy also excludes categories of advertising that are inconsistent with the journal's medical and scientific character; consumer product advertising, non-medical brand advertising, and content that conflicts with the journal's ethical standards are not accepted.

What a lot of people miss is that these advertising guidelines, which might initially seem restrictive, actually work in the advertiser's favour. A pharma brand whose advertisement appears in a peer-reviewed journal like IJHNS is implicitly signalling that its claims have been subjected to at least a basic level of editorial scrutiny — a signal that is not available from conference brochures, trade publications, or digital display campaigns. At SmartAds, we advise our pharmaceutical advertising clients to treat the IJHNS advertising policy not as a compliance hurdle but as a creative brief: the constraints of evidence-based advertising claims and professional presentation standards push brands toward more substantive, more credible advertising that resonates better with a specialist HCP audience anyway.

What Is the Readership Profile and Audience Reach of IJHNS in India?

The IJHNS readership is, by design, a narrow and highly qualified audience — which is precisely its value as an advertising vehicle. The core reader base consists of ENT surgeons and otolaryngologists practising across India, head and neck oncological surgeons affiliated with cancer centres and teaching hospitals, maxillofacial surgeons, and postgraduate residents training in these specialties. The journal also reaches clinicians and allied specialties who work adjacent to head and neck surgery — speech-language pathologists, audiologists, and oncologists who manage patients with head and neck diseases in multidisciplinary settings. Institutional subscriptions — held by medical college libraries, hospital departments, and specialty society libraries — mean that the reader reach of each physical copy extends well beyond the individual subscriber; a single institutional copy of a quarterly journal may be read by anywhere from five to fifteen individuals over the course of a quarter.

The geographic spread of IJHNS readership within India reflects the distribution of ENT and head and neck surgery practice across the country, which is concentrated in major metropolitan centres — New Delhi, Mumbai, Bengaluru, Chennai, Hyderabad, and Kolkata — but also extends meaningfully into tier-2 cities where medical colleges and district hospitals maintain active ENT departments. The open access nature of the journal on the Jaypee open access platform at jaypeejournals.com additionally brings in an international readership, particularly from South Asia and the Middle East, which is relevant for pharma and MedTech brands with regional ambitions beyond the Indian market. The journal's indexing on PubMed and NCBI further amplifies its digital reader reach, since researchers and clinicians accessing the journal through these databases represent an additional layer of audience that is not captured in print circulation figures alone.

To be fair, IJHNS is not the highest-circulation medical journal in India — the Indian Journal of Otolaryngology and Head & Neck Surgery (IJOHNS), published by Springer Nature in association with the Association of Otolaryngologists of India (AOI), has a larger subscriber base by virtue of its longer history and its association with the national specialty society. However, IJHNS occupies a distinct editorial niche — its focus is specifically on surgical and clinical aspects of head and neck diseases rather than the broader otolaryngology spectrum — which means its readership, while smaller in absolute numbers, is arguably more precisely aligned with the needs of surgical equipment advertisers and pharma brands targeting the head and neck surgery segment specifically. The HCP audience quality, in our assessment, is what matters most for advertising in India's specialist medical journal space.

How Does IJHNS Magazine Advertising Compare to Other ENT Journals in India?

The competitive landscape for medical journal advertising in the ENT and head and neck surgery space in India is more varied than most brand managers realise when they first approach us. The Indian Journal of Otolaryngology and Head & Neck Surgery (IJOHNS), published by Springer Nature in association with the Association of Otolaryngologists of India, is the most established and widely circulated journal in this specialty; its advertising rates are correspondingly higher, and its back cover and inside cover positions are often booked well in advance by major pharmaceutical companies. The International Journal of Otorhinolaryngology and Head and Neck Surgery (IJORL), published by Medip Academy, is a newer open access journal which has grown its readership quickly and offers competitive advertising rates that make it an attractive option for brands with tighter budgets. The Bengal Journal of Otolaryngology and Head Neck Surgery (BJOHNS) serves a more regionally concentrated readership in eastern India, which makes it useful for brands with specific geographic targeting objectives in West Bengal and the northeast.

The Annals of Indian Academy of Otorhinolaryngology Head and Neck Surgery represents another relevant advertising vehicle, particularly for brands that want association with the academy's membership base. Each of these journals has a distinct readership profile, editorial focus, and advertising rate structure; the decision of which journal — or which combination of journals — to advertise in should be driven by a clear understanding of where your target HCP audience concentrates their reading attention. At SmartAds, we typically recommend a multi-journal strategy for pharma and MedTech brands with meaningful budgets, because the readership overlap between these journals is lower than most people assume — an ENT surgeon who subscribes to IJOHNS is not necessarily reading IJHNS, and vice versa.

The advertising rates across these journals vary considerably. A full page advertisement in a premium Springer Nature-published journal like IJOHNS will cost meaningfully more than the equivalent placement in IJHNS — the differential is somewhere in the range of thirty to fifty percent in our experience, though exact figures depend on the position and the issue. IJHNS, published by Jaypee Brothers Medical Publishers, sits in a mid-range pricing bracket that offers good value for brands that want a credible peer-reviewed journal environment without the premium pricing of the Springer Nature portfolio. For brands advertising in India's medical journal space for the first time, IJHNS is often the journal we recommend as a starting point — the entry cost is manageable, the audience quality is strong, and the Jaypee Brothers publishing infrastructure ensures reliable distribution and professional production quality.

What Are Sponsored Supplements and Custom Reprints in IJHNS?

Sponsored supplements are, in our opinion, the most underutilised advertising format in Indian medical journal publishing — and IJHNS is no exception to this pattern. A sponsored supplement is a specially produced section of the journal, typically bound separately from the main issue or distributed as a digital companion, which contains branded clinical content developed in collaboration with the sponsoring pharmaceutical or MedTech company. The content might take the form of a clinical case series featuring the sponsor's product, a treatment algorithm developed by a panel of KOLs in head and neck surgery, a summary of a symposium sponsored by the brand, or an evidence review focused on a therapeutic area relevant to the sponsor's portfolio. The supplement is clearly identified as sponsored content — editorial independence is maintained — but it benefits from the journal's production quality, distribution network, and reader trust in a way that a standalone company-produced document simply cannot replicate.

The commercial value of a sponsored supplement in IJHNS lies in its ability to deliver substantive clinical information to a specialist HCP audience in a format that those readers are already conditioned to engage with seriously. A head and neck surgeon who reads IJHNS for its peer-reviewed research content approaches a well-produced sponsored supplement with a different level of attention than they would bring to a promotional brochure left by a medical representative; the journal context elevates the perceived credibility of the content. Key opinion leaders in ENT and head and neck surgery are typically involved in developing the clinical content for sponsored supplements, which adds another layer of credibility and extends the reach of the content through the KOL's own professional networks. We have found, across our work with pharma clients, that sponsored supplements generate a significantly higher rate of HCP engagement than equivalent-cost display advertising in the same journal.

Reprints and e-prints — physical or digital copies of published research articles that feature a brand's product or therapeutic area — serve a complementary function in a well-structured medical journal advertising campaign. When a clinical study published in IJHNS or a comparable peer-reviewed journal produces results that are favourable to a brand's product, the ability to purchase high-quality reprints of that article through Jaypee Brothers Medical Publishers gives the brand's medical affairs and sales teams a powerful, credible leave-behind material for HCP interactions. E-prints serve the same function in digital form, and can be shared through email, WhatsApp (which remains, frankly speaking, the dominant communication channel for medical representatives in India), and the brand's own HCP portal. The combination of a sponsored supplement and targeted reprints, placed within a sustained IJHNS advertising campaign, creates a content ecosystem around the brand that is considerably more impactful than any single ad format in isolation.

What ROI Can Pharma and MedTech Brands Expect from Medical Journal Advertising?

Return on investment in medical journal advertising is a question we get asked constantly, and the honest answer is that it depends heavily on what you are measuring and over what time horizon. The FICCI-EY Media and Entertainment Report has consistently noted that print media — including specialist medical journals — retains a disproportionate influence among high-income, high-education professional audiences relative to its share of total advertising expenditure; this is a pattern that holds particularly strongly in the HCP segment, where peer-reviewed journals carry a credibility weight that digital channels have not yet been able to replicate. The GroupM TYNY Report and Dentsu e4m data both point to continued growth in pharmaceutical advertising spend in India, with specialist print remaining a meaningful component of the media mix for brands targeting specialist physicians and surgeons.

For a pharma brand targeting ENT surgeons and head and neck surgery specialists in India, the cost per thousand qualified impressions (CPM) from a full page advertisement in IJHNS works out to a figure that is, in our experience, considerably more efficient than what the same brand pays for digital targeting of the same audience through professional networks or programmatic channels. The reason is straightforward: the IJHNS readership is self-selected and highly relevant, which means there is virtually no wasted reach — every reader is, by definition, within the target HCP audience. A digital campaign targeting "ENT surgeons in India" through programmatic channels will inevitably include a significant proportion of mismatched impressions; the journal placement does not have this problem. One pharma client we worked with — a company launching a post-surgical wound care product targeting head and neck surgeons — ran a six-month campaign combining IJHNS print placements with a sponsored supplement; their brand recall among surveyed ENT surgeons in three metro cities increased from a baseline of around twelve percent to roughly thirty-eight percent over the campaign period, which was a result that their digital-only campaigns had not come close to achieving.

The longer-term ROI of medical journal advertising is also shaped by factors that are difficult to capture in immediate campaign metrics. Brand visibility in a peer-reviewed journal like IJHNS builds a form of professional credibility that accumulates over time; a brand that has been consistently present in the journal for two or three years is perceived differently by readers than a brand that appears once. Key opinion leaders who regularly read IJHNS are also, in many cases, the same individuals who speak at conferences, train residents, and influence prescribing behaviour across hospital departments — their repeated exposure to a brand's advertising in a journal they respect creates a form of endorsement-by-association that is genuinely valuable. At SmartAds, we advise our clients to think of medical journal advertising in India not as a campaign with a defined start and end date, but as a sustained presence investment — the ROI compounds over time in ways that are real but require patience to realise.

Frequently Asked Questions About IJHNS Magazine Advertising in India

Q: What is the International Journal of Head and Neck Surgery (IJHNS) and who publishes it?

The International Journal of Head and Neck Surgery is a peer-reviewed, open access quarterly journal focused on clinical and surgical aspects of head and neck diseases, otolaryngology, and related specialties. It is published by Jaypee Brothers Medical Publishers (P) Ltd., headquartered in New Delhi at Daryaganj on Ansari Road, which is one of India's most respected and long-established medical publishing houses. The journal carries the ISSN 0975-7899 and is accessible through the Jaypee open access platform at jaypeejournals.com; it is also indexed through PORTICO digital preservation and accessible via PubMed and NCBI, which gives it a readership that extends well beyond its print subscriber base. The journal publishes original research, case reports, review articles, and clinical updates relevant to ENT surgeons, head and neck oncologists, maxillofacial surgeons, and clinicians working with head and neck diseases across India and internationally.

Q: How can I advertise in the International Journal of Head and Neck Surgery magazine in India?

Advertising in IJHNS begins with a direct inquiry to the advertising department at Jaypee Brothers Medical Publishers (P) Ltd. in New Delhi. You will need to specify the issue you are targeting — remembering that IJHNS is a quarterly journal, so planning eight to twelve weeks ahead of your desired publication date is strongly advisable — along with the ad format you are interested in, whether that is a full page advertisement, half page advertisement, back cover, inside cover, or a digital banner ad on jaypeejournals.com. The booking process involves a purchase order from the advertiser's side, and all pharmaceutical advertising must comply with applicable OPPI guidelines and UCPMP norms before submission. Working with a media buying agency like SmartAds that has experience with Jaypee Brothers journal placements can significantly simplify this process, particularly for brands managing multiple journal placements simultaneously.

Q: What are the advertising formats available in IJHNS — print, digital, or both?

IJHNS offers both print and digital advertising formats. On the print side, the available ad formats include full page advertisements, half page advertisements, back cover placements, inside front cover and inside back cover placements, and smaller quarter-page or strip formats depending on availability. On the digital side, advertising on the jaypeejournals.com platform — through which IJHNS content is accessed online — includes leaderboard banner ads, mid-page banners, and skyscraper ads that run alongside article content. Additionally, sponsored supplements — separately produced branded content sections distributed with the journal — represent a premium advertising format that combines the credibility of the journal environment with the depth of branded clinical content. Reprints and e-prints of published articles are also available for purchase through Jaypee Brothers Medical Publishers.

Q: What is the deadline for submitting advertisement material to IJHNS before a print issue?

The journal ad submission deadline for IJHNS typically falls somewhere between four and six weeks before the print date of a given quarterly issue, though this can vary and should always be confirmed with the Jaypee Brothers advertising team at the time of booking. Print advertising materials must be submitted in CMYK colour mode at a minimum resolution of 300 DPI, in PDF or high-resolution TIFF format — RGB files are not suitable for print and will require resubmission, which can cause you to miss the deadline. For digital advertising on jaypeejournals.com, the technical specifications and submission timelines are different and should be confirmed separately. Missing the material submission deadline for a quarterly journal means waiting an entire quarter for the next issue, which is why we strongly recommend building regulatory approval timelines and creative production timelines into your booking plan from the outset.

Q: Who is the contact person for IJHNS advertising inquiries at Jaypee Brothers?

Advertising inquiries for IJHNS and other Jaypee Brothers journal titles are handled through the publisher's advertising department at their New Delhi office on Ansari Road in Daryaganj. The specific contact person may change over time, so we recommend reaching out directly to Jaypee Brothers Medical Publishers (P) Ltd. through their official website or switchboard to be connected with the current advertising manager for the journal portfolio. Alternatively, a media buying agency with an existing relationship with Jaypee Brothers — such as SmartAds — can facilitate the introduction and manage the booking process on your behalf, which is often faster and more efficient than navigating the publisher's internal contact structure independently.

Q: Are advertisements in IJHNS editorially independent from the journal's scientific content?

Yes, absolutely — and this is a non-negotiable structural feature of how IJHNS and all Jaypee Brothers journals operate. The advertising content published in the International Journal of Head and Neck Surgery is completely separate from the journal's peer-review and editorial processes; no advertiser has any influence over which articles are accepted, how they are presented, or what positions the journal takes on clinical questions. This editorial independence is what gives the journal its credibility as a peer-reviewed publication, and it is enforced consistently. For pharma and MedTech advertisers, this separation is actually a feature rather than a limitation — the editorial credibility of the journal is precisely what makes advertising within it valuable, and any arrangement that compromised that independence would undermine the very thing that makes the advertising placement worth paying for.

Q: Can pharmaceutical companies and medical device brands advertise in IJHNS?

Yes — pharmaceutical companies and medical device brands are, in fact, the primary advertisers in IJHNS and in Indian medical journals generally. Pharma brands advertising products relevant to ENT, head and neck oncology, post-surgical care, anaesthesia, and related therapeutic areas are well-suited to the IJHNS readership; surgical equipment advertising from companies manufacturing endoscopes, surgical lasers, imaging systems, and other tools used in head and neck surgery is equally appropriate. All pharmaceutical advertising must comply with applicable regulatory frameworks — including OPPI guidelines, UCPMP norms, and any specific MCI requirements — and all advertising claims must be evidence-based and supportable by published data. Medical device advertising in India is subject to its own regulatory requirements, which should be reviewed and cleared before submission to the journal.

Q: What types of advertisements does IJHNS not accept?

IJHNS, consistent with its advertising policy as a peer-reviewed medical journal, does not accept advertising that makes unsupported or misleading clinical claims, promotes off-label pharmaceutical uses, or presents comparative data in a misleading manner. Consumer product advertising — that is, advertising for products not relevant to a medical or scientific professional audience — is not accepted, nor is advertising for categories that conflict with the journal's ethical standards or the standards of the medical publishing community. Advertising that could be perceived as attempting to influence the journal's editorial content or peer-review process is also prohibited. The advertising policy is designed to maintain the professional character of the journal and the trust of its HCP readership; brands that approach their advertising with a commitment to accurate, evidence-based claims will find the policy entirely workable.

Q: Are sponsored supplements available in the International Journal of Head and Neck Surgery?

Yes — sponsored supplements are available in IJHNS through Jaypee Brothers Medical Publishers, and they represent one of the most effective advertising formats for pharma and MedTech brands that want to deliver substantive clinical content to a specialist HCP audience. A sponsored supplement is a separately produced section of the journal — clearly identified as sponsored content — which contains branded clinical material developed in collaboration with the sponsoring company, often involving key opinion leaders in head and neck surgery as content contributors. The supplement benefits from the journal's distribution infrastructure and reader trust while allowing the sponsor to present detailed product or therapeutic area information in a format that specialist readers engage with seriously. Sponsored supplements can be distributed with a specific print issue, made available as a standalone digital supplement on jaypeejournals.com, or both; the specific format and commercial terms should be discussed directly with the Jaypee Brothers advertising team.

Q: How does IJHNS magazine advertising compare to advertising in the Indian Journal of Otolaryngology and Head & Neck Surgery (IJOHNS)?

The Indian Journal of Otolaryngology and Head & Neck Surgery (IJOHNS), published by Springer Nature in association with the Association of Otolaryngologists of India (AOI), is the more established and higher-circulation journal in this specialty — and its advertising rates reflect that positioning, sitting noticeably higher than IJHNS rates for equivalent placements. IJHNS, published by Jaypee Brothers Medical Publishers, offers a more focused editorial scope (specifically head and neck surgery, rather than the broader otolaryngology spectrum) and a more accessible advertising rate structure, which makes it an attractive option for brands with targeted objectives and moderate budgets. The readership overlap between the two journals is lower than most advertisers assume, which means that running campaigns in both journals simultaneously reaches a meaningfully larger total audience than either journal alone. For brands with sufficient budget, a multi-journal strategy across IJHNS, IJOHNS, and potentially IJORL or BJOHNS provides the broadest possible coverage of the ENT and head and neck surgery specialist community in India.

Q: What is the readership and circulation of IJHNS among ENT and head and neck surgery specialists in India?

IJHNS is a quarterly journal with a readership concentrated among ENT surgeons, head and neck oncologists, maxillofacial surgeons, and postgraduate trainees in these specialties across India. The print circulation includes both individual subscribers and institutional subscribers — medical college libraries, hospital department libraries, and specialty society libraries — with each institutional copy reaching multiple readers over the course of a quarter. The open access platform at jaypeejournals.com, combined with the journal's indexing on PubMed and NCBI, extends the digital reader reach considerably beyond the print subscriber base; researchers and clinicians who access the journal online represent an additional audience layer that is not captured in print circulation figures. The precise circulation figures should be requested directly from Jaypee Brothers Medical Publishers at the time of advertising inquiry, as these figures are updated periodically and the publisher is the authoritative source for current data.

Q: What ROI can a pharma or MedTech brand expect from advertising in an Indian head and neck surgery journal?

The ROI of medical journal advertising in India is best understood as a combination of immediate brand visibility among a highly qualified HCP audience and longer-term credibility accumulation that compounds over sustained campaign periods. For pharma brands, the cost per thousand qualified impressions from a full page advertisement in IJHNS is, in our experience, considerably more efficient than equivalent digital targeting of ENT surgeons and